Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: e-mailed this PR to the Investors Relation Dept of PTSC

I did too! and I left a message on the answering machine. Let's see if we get a response. I did not name the news company reporting the story. I also sent an email to the news company asking if the story is a mistake or is true. On that let's see if they drop the story or not. The longer it stays up the more it seems true. If one other wire picks up the story then what do we have to think? Just how much did PTSC get on the latest license??? Enough to pay a dividend? And a dividend would get the hounds of the backs of the BoD, IMO.

Share
New Message
Please login to post a reply